5% stakes
Redmile Group
Institution
- 5% stake reports
- 30
- 5% stake stocks
- 15
- Latest report
- 26/09/28
5% stake reports
| Stock | ||
|---|---|---|
| Electra Therapeutics ETRA09/28 | 8.7%5,462,881 sh | First report |
| Nurix Therapeutics NRIX08/14 | 8.1%8,782,256 sh | −1.8pp |
| Scholar Rock Holding SRRK08/14 | 3.6%4,311,092 sh | −4.0pp |
| Atara Biotherapeutics ATRA07/24 | 9.9%950,994 sh | +0.0pp |
| Shattuck Labs STTK07/17 | 9.9%10,019,421 sh | +0.0pp |
| Shattuck Labs STTK06/11 | 9.9%9,819,084 sh | +0.0pp |
| AgomAb Therapeutics AGMB05/15 | 5.6%2,735,926 sh | First report |
| Scholar Rock Holding SRRK05/15 | 7.6%9,066,621 sh | −2.3pp |
| Stoke Therapeutics STOK05/15 | 6.7%4,164,120 sh | −1.3pp |
| Immunome IMNM05/15 | 4.9%5,558,885 sh | −0.3pp |
| Alx Oncology Holdings ALXO05/15 | 6.8%9,214,188 sh | −1.7pp |
| Atara Biotherapeutics ATRA05/14 | 9.9%950,994 sh | +0.0pp |
| Fate Therapeutics FATE04/22 | 14.9%18,229,078 sh | +0.0pp |
| Absci ABSI04/14 | 4.9%7,607,449 sh | −0.5pp |
| ADC Therapeutics ADCT04/06 | 9.9%12,692,841 sh | −2.8pp |
| Absci ABSI03/26 | 5.4%8,253,316 sh | −1.1pp |
| Immunome IMNM02/17 | 5.2%5,718,385 sh | −1.0pp |
| ADC Therapeutics ADCT02/17 | 12.7%15,666,731 sh | −1.3pp |
| Atara Biotherapeutics ATRA25/11/14 | 9.9%751,223 sh | +0.0pp |
| Zymeworks ZYME25/11/14 | 4.9%3,705,750 sh | −0.7pp |
